Weight Loss Pill Recalled, Say FDA Authorities
Here’s a new diet pill recall that the FDA warns contains a banned substance that could be hazardous to some users.
A new recall alert posted by the FDA warns consumers that users of Dream Body Weight Loss capsules could be putting themselves at an increased health risk after discovering in their testing labs that some samples contain the banned ingredient sibutramine.
According to the FDA:
Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This undeclared ingredient makes these products unapproved new drugs for which safety and efficacy have not been established. These products may also interact in life-threatening ways with other medications a consumer may be taking.
Dream Body Weight Loss Recall Info
Dream Body Weight loss is voluntarily recalling the following lots of their products:
• Dream Body Extreme Gold 800mg 30 gold capsules
• Dream Body 450mg 30 white capsules
• Dream Body Advanced 400mg 30 purple capsules
The dietary supplements are packaged in clear packer jars and brown foil packets with the UPC code 6903023120128 distributed Nationwide from January 2013 to June 16, 2016 to consumers via retail sales and internet transactions.
As of this date, Dream Body Weight Loss has not received any reports of adverse events related to their recalled products. However, users are advised to immediately discontinue use of the recalled capsules and may contact Dream Body Weight Loss by telephone at 888-882-7612 and/or e-mail at [email protected] Monday- Friday 9am to 630pm CST for a refund.
In Case of an Adverse Reaction to the Supplement
The FDA requests that any users of the recalled capsules experiencing an adverse reaction with the use of this product to make a report to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178